Mounjaro®
Starting from £179.99/mo
Start journey Learn moreIn the UK, Wegovy 0.5 mg is one step on a prescribed titration schedule, not a standalone purchase — and the price you pay privately reflects the cost of a full four-week pen at that dose, plus whatever the provider includes around it. Private Wegovy pricing typically ranges across doses and providers, with the 0.5 mg pen generally sitting toward the lower end of the market. Semaglutide (Wegovy) is a prescription-only medicine, which means a prescriber must assess your suitability before it can be dispensed — the price of treatment is always the price of clinically supervised supply, not just a box in the post.
At your door the next working day.
Free, tracked, plain packaging.
BMI isn't the whole story, but it's where clinicians start. Check yours in ten seconds — nothing is stored, nothing is shared.
Ten seconds. Private — nothing is stored or shared.
Your result updates live in the card alongside.
Your result
Your BMI is
—
which is in the healthy weight range
Start journeyBMI doesn't determine eligibility — only a clinician can assess whether treatment is right for you.
The problem
The nume way
clinician review. Free next working day delivery.
How it works
Tell us about your health, history and goals. Free, online, and confidential — no commitment, no waiting room.
Our team reviews your health the same day — never an algorithm, and approves your treatment there and then if eligible.
Order by 12pm, dispatched same day, delivered free the next working day — the nume Promise.
NICE's recommendation for semaglutide (TA875) sets out that Wegovy is intended for adults with a BMI of 35 or above alongside at least one weight-related condition, used for a maximum of two years within a specialist weight management service. That framing matters for price, because it signals what legitimate treatment looks like: a clinical structure, not a single pen. The 0.5 mg dose is a titration step, semaglutide begins at 0.25 mg and moves through 0.5 mg, 1.0 mg, 1.7 mg, and 2.4 mg at roughly four-week intervals, as directed by the prescriber. A question our prescribers hear most weeks is whether the 0.5 mg pen is cheaper because it is a lower dose, and the short answer is that pricing follows market and supply-chain factors more than dose strength. The STEP 1 trial, published in the New England Journal of Medicine, showed roughly 15% average weight loss over 68 weeks at the 2.4 mg maintenance dose; those results depend on completing the full titration, not stopping at an early step.
When you compare prices for Wegovy 0.5 mg across UK providers, you are usually seeing the cost of the pen alone, and if you want to understand what the 0.5 mg Wegovy cost actually involves, it helps to look beyond that single figure. What headline prices frequently leave out: the consultation fee (some providers charge this separately), the prescription fee, delivery, and any aftercare or clinical follow-up when you move to your next dose. Those add-ons can close a seemingly wide gap quickly. There is also the question of what happens when you need to escalate, moving from 0.5 mg to the 1 mg pen requires another clinical review, and not every provider makes that straightforward or free. Eli Lilly's list-price increase for Mounjaro in September 2025, widely reported in the trade press, is a reminder that wholesale costs for GLP-1 medicines are not fixed; private prices for Wegovy can shift too. The NICE appraisal TA875 is publicly available if you want to read exactly what the regulator expects from a well-run semaglutide service, it is a useful benchmark for judging any provider's offer.
At nume, one price covers everything: consultation, prescriber review, the medicine itself, and free next-working-day delivery via DPD. There are no add-on fees at the checkout, no subscription you have to cancel, and no separate charge when your prescriber reviews your case before each repeat order. That is a deliberate choice. Cheapest is not a race we entered, because the value of a prescription medicine sits in the quality of the clinical oversight around it, not in trimming a few pounds from the list price. You can see current treatment pricing, including for all Wegovy doses, on our treatment page, we do not print per-pen prices in body copy, because prices can be updated and we would rather you see the live figure. For a broader picture of what the Wegovy 0.5 price looks like in context, our Wegovy price guide covers the full dose ladder in context. And if you want to read about the medicine itself before thinking about cost, our Wegovy overview page is a good starting point.
The MHRA has issued public warnings about fake weight-loss pens sold online, including through social media, some of which have contained insulin rather than semaglutide. Any seller offering Wegovy without a prescription from a verified pharmacy is a significant safety risk, and unusually low prices are consistently among the warning signs. You can check whether any online pharmacy is GPhC-registered at the GPhC register, a genuine, regulated pharmacy will be listed there. At nume, our GPhC premises registration number is 9012878, verifiable directly on the register. If you are wondering how much Wegovy 0.5 mg is from a regulated UK pharmacy, the right question is not whether it is the lowest but what it includes, who is reviewing your case, and whether the pharmacy supplying it is accountable to a UK regulator. Many people also ask whether Wegovy is taken weekly or monthly, which affects how you think about ongoing costs over the course of treatment. When you are ready to compare options, our guide to the cheapest Wegovy 0.5 mg available in the UK explains what to look for in a fairly priced, clinically sound service. If you are ready to find out whether Wegovy is clinically suitable for you, our prescribers are available the same day. Speak to our prescribers through a free consultation, no obligation, no upfront fee.
The people
Superintendent Pharmacist (GPhC No. 2217101)
Accountable for the safe running of our registered pharmacy, from every dispensing check to every dispatch.
Clinical Lead (GPhC No. 2231744)
Sets our clinical standards and checks everything we publish against current MHRA guidance.
Independent Prescriber (GPhC No. 2084501)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.
Independent Prescriber (GPhC No. 2083426)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.